Despite a high prevalence of schizophrenia patients with comorbid substance abuse, little is known about possible impacts on the brain. Hence, our goal was to determine whether addicted and non-addicted schizophrenic patients suffer from different brain deficits. We were especially interested to determine if grey matter volumes were affected by impulsivity. We hypothesized that (comorbid) substance abuse would be associated with enhanced impulsivity and that this enhanced impulsivity would be related to grey matter volume deficits in prefrontal areas. We employed a voxel-based morphometry approach as well as neuropsychological assessment of executive functions and trait impulsivity in 51 participants (age range 23-55). The schizophrenia group comprised 24 patients (12 patients with paranoid schizophrenia and 12 with additional comorbid substance use disorders). The comparison group comprised 27 non-schizophrenic individuals, matched by age and education (14 healthy individuals and 13 patients with substance use disorders). Total grey matter volume deficits were found in all patient groups as compared with healthy controls but were largest ($8%) in both addicted groups. While grey matter volume losses in lateral orbitofrontal and temporal regions were affected by schizophrenia, volume decreases of the medial orbitofrontal, anterior cingulate and frontopolar cortex were associated with addiction. Compared with non-addicted schizophrenics, comorbid patients showed significant volume decreases in anterior cingulate, frontopolar and superior parietal regions. Additionally, they showed an increased non-planning impulsivity that was negatively related to grey matter volumes in the same regions, except for parietal ones. The present study indicates severe grey matter volume and functional executive deficits in schizophrenia, which were only partially exacerbated by comorbid addiction. However, the relationship between non-planning impulsivity and anterior cingulate and frontopolar grey matter volumes points to a specific structure-function relationship that seems to be impaired in schizophrenia-addiction comorbidity.
Introduction
Comorbid substance abuse in patients with schizophrenia is very common. Approximately 50% of these patients fulfil the criteria for both schizophrenia and substance use disorder over their lifetime (Regier et al., 1990) . However, persisting comorbid substance abuse is associated with a negative outcome. This includes an overall reduced quality of life, more frequent and longer periods of hospitalization, higher relapse rates, less treatment compliance and higher incidence of violent behaviour (Fazel et al., 2009) .
Despite these adverse outcomes in schizophrenia-addiction comorbidity, little is known about its actual impacts on the brain or their functional relevance. However, structural brain abnormalities in schizophrenia were identified by using voxel-based morphometry that revealed impairments, especially in frontotemporal cortices (Davatzikos et al., 2005; Honea et al., 2005; Williams, 2008) . Most voxel-based morphometry studies to date have focused on chronic patients and showed rather consistent volume decreases in superior and medial temporal cortices (Honea et al., 2005; Williams, 2008) . Moreover, there is accumulating evidence for volume reductions in frontal brain regions (Williams, 2008) resulting from meta-analyses of studies regarding first-episode schizophrenia and other high-risk groups, such as first-degree relatives.
Apart from alcohol misuse, substances commonly abused in schizophrenic patients include nicotine, cocaine and cannabis (Winklbaur et al., 2006) . These substances are reinforced by an increased dopaminergic activity, particularly in the mesolimbic dopamine system (Gerdeman et al., 2003) . As substance abuse increases the mesolimbic dopamine activity (Gerdeman et al., 2003) and leads to neurotoxic damage within frontosubcortical circuits in the long term (Spanagel and Heilig, 2005) , it may exacerbate the presumed pre-existing dysregulation of the dopamine system and cause an additional disruption within frontosubcortical circuits in patients with schizophrenia (Siever and Davis, 2004) . Furthermore, recent structural magnetic resonance imaging (MRI) studies documented morphological changes in the frontal lobe of patients suffering from different types of drug addiction (Jernigan et al., 1991; Liu et al., 1998; Chanraud et al., 2007) .
Unfortunately, only a few studies on brain dysmorphology in addicted and non-addicted schizophrenic patients have been carried through and these have mainly focused on alcohol abuse. Furthermore, their results were partly inconclusive. While a recent study did not show significant differences between schizophrenic patients with and without comorbid alcoholism (Wobrock et al., 2009) , the largest study (Mathalon et al., 2003) at hand documented a compounding, additive effect in schizophreniaalcoholism comorbidity in prefrontal cortex areas, important for cognitive functioning.
Regarding cognition, both schizophrenia and substance use disorders are related to functional impairment Lundqvist, 2005; Minzenberg et al., 2009) . However, little is known about the status of cognitive and executive functions in comorbid patients. Executive functions represent supervisory cognitive coordination processes allowing for flexible, goal-directed behaviour, particularly in novel situations (Norman and Shallice, 1986) . They depend upon the functional integrity of frontosubcortical circuits that are affected both in schizophrenia (Camchong et al., 2006) and substance use disorders (Garavan and Stout, 2005) . It has been suggested that goal-directed behaviours of addicted patients in addiction relevant situations are mainly driven by automatic processes and that their ability to interrupt the maladaptive automatic schemata is disturbed (Tiffany, 1990) . Continuing abstinence requires the ability to inhibit automatic response routines leading to drug consumption and the ability to shift the cognitive focus to alternative behaviours and goals. Accordingly, poor response inhibition, as part of the impulsivity concept, has been found to predict problem drinking and illegal drug use (Nigg et al., 2006) . Thus, the impulsivity construct is of central importance for substance use disorders or schizophrenia-addiction comorbidity (Moeller et al., 2002) . It can be conceptualized as a personality trait, characterized by acting quickly and without planning in order to satisfy a desire (Kreek et al., 2005) . Hence, impulsivity is a complex, multifaceted construct including cognitive, personality and behavioural components (e.g. risk taking, sensation seeking and behavioural disinhibition) (Nigg, 2000) . Impulsivity has been related to an early use of illegal substances, a high susceptibility to developing a substance use disorder (Tarter et al., 2003) and a decrease of local grey matter volumes, particularly in orbito-frontal regions (Matsuo et al., 2009) .
These findings indicate that comorbid patients should show more distinct executive deficits and in particular, higher trait impulsivity than non-addicted schizophrenics. Yet, while studies regarding impulsivity are still lacking, studies regarding executive functions revealed inconclusive results (Addington and Addington, 1997; Pencer and Addington, 2003; Herman, 2004; .
The present investigation therefore sought to determine whether executive functions and trait impulsivity show different impairments in patients with schizophrenia, with and without comorbid substance use disorder, and especially, whether or how brain volumes are associated with impulsivity. We hypothesized that (comorbid) substance abuse would be associated with enhanced trait impulsivity and that this enhanced impulsivity would be correlated with grey matter volume deficits in prefrontal areas or frontosubcortical circuits, relevant for executive control.
Methods Subjects
A total of 51 male individuals (age range 23-55 years) were recruited for this study. The schizophrenia group comprised 24 chronic patients, diagnosed as having Diagnostic and Statistical Manual of Mental Disorders, fourth edition paranoid schizophrenia (DSM IV: 295.30) and was subdivided into two subsamples. The comorbid sample (SZ+A) comprised 12 paranoid schizophrenic patients who had a history of alcohol dependence (DSM IV: 303.90) and a misuse of substances other than alcohol: cannabis (n = 3; DSM IV: 305.20), medicinal drugs (n = 1; DSM IV: 305.40), stimulants (n = 1; DSM IV: 305.70) or multiple substances (n = 5; DSM IV: 304.80). The 'SZ' sample comprised 12 patients with paranoid schizophrenia without current or lifetime alcohol or other substance problems, except for nicotine. Patients were recruited from the outpatient care of the Department of Psychiatry and Psychotherapy, University of Duisburg-Essen, and underwent medical screening and psychiatric assessment. Diagnosis was based on consensus between a research psychologist conducting a clinical interview and a trained research assistant implementing the Structured Clinical Interview for DSMIV (SCID-I and SCID-II) (Wittchen et al., 1996) . Symptom severity was evaluated using the Positive and Negative Syndrome Scale (Kay et al., 1987) , executed by two raters with an established inter-rater reliability (mean Pearson's correlation: 0.758). All schizophrenic patients were taking antipsychotic medication [typical (n = 1), atypical (n = 12), typical and atypical (n = 11)] and were physically healthy at the time of scanning and testing.
The comparison group comprised 27 non-schizophrenic individuals and was also subdivided into two subsamples. The addicted patients sample comprised 13 patients with a history of alcohol dependence (DSM IV: 303.90) and was matched with the comorbid sample regarding other substances than alcohol abused over their lifetime: cannabis (n = 4; DSM IV: 305.20), opiates (n = 1; DSM IV: 305.50), stimulants (n = 1; DSM IV: 305.70), multiple substances (n = 5; DSM IV: 304.80). They were recruited from specialized aftercare facilities in Essen. The healthy control group sample (n = 14), recruited by advertisement and local employment agencies, was screened via telephone and then assessed by implementing structured psychiatric SCID interviews. The healthy control group was excluded for Axis I psychopathology or lifetime history of substance abuse. Both non-schizophrenic groups were matched by age, education level and duration of substance abuse or dependence, where appropriate. They did not have a first-degree relative with psychotic episodes. Eighty-three percent (n = 20) of the schizophrenic patients and 78% (n = 21) of the non-schizophrenic group smoked.
General exclusion criteria included a history of significant medical or neurological illness, head injury resulting in loss of consciousness (430 min), inadequate knowledge of the German language, left-handedness and mental retardation (IQ 590), which was tested with a multiple choice vocabulary test (Mehrfachwahl-WortschatzIntelligenztest-B, an indicator of pre-morbid abilities) (Lehrl et al., 1995) . All patients with a history of substance abuse had not consumed any substances for at least 1 year (supported by urine analysis). Tokyo, 2004) . After a detailed description of the study, written informed consent was obtained from all participants.
Assessment of addiction severity
The Michigan Alcohol Screening Test (Selzer, 1971 ) and the Drug Abuse Screening Test-20 (Skinner, 1982) were used to quantify the exposure to alcohol and illegal drugs. The Michigan Alcohol Screening Test was developed as a quick and effective screening method for lifetime alcohol-related problems and alcoholism, and consists of 25 items. The Drug Abuse Screening Test-20, a shortened version of the 28-item Drug Abuse Screening Test, designed to identify drug-use related problems, was also used as a lifetime measure.
Cognition and impulsivity assessments
All participants underwent neuropsychological assessments to explore different executive domains (cognitive flexibility, response inhibition, planning and visuospatial memory) and trait impulsivity.
The Trail Making Test (Reitan and Wolfson, 1985) and a computerized version of the modified Wisconsin Card Sorting Task (WCST) (Nelson, 1976) were used to assess the ability to alter a behavioural response mode in case of changing contingencies [reactive cognitive flexibility (set-shifting)]. Furthermore, a test of verbal fluency was applied to measure spontaneous cognitive flexibility and speed of access to semantic information (in this study, animals with a given time period of 60 s).
The Corsi block tapping Test (Schellig, 1997) and the visual reproduction task from the Wechsler Memory Scale, Revised (Wechsler, 1987) were applied to assess visuospatial memory.
Inhibition performance was assessed by the number of perseverative errors in the WCST and a Go/No-go task, taken from a German standard battery (Zimmermann and Fimm, 2009) .
A computerized Tower of London task (Schall et al., 2003) , an adaptation of the Tower of Hanoi, was used to measure the planning behaviour of our study participants. And finally, to quantify impulsivity, we used the Barratt Impulsiveness Scale (BIS-11) (Barratt, 1994) , which is regarded as the most commonly used self-report measure of impulsivity. In its revised form, it results in a total score and three subscale scores: attention, motor and non-planning impulsivity (Patton et al., 1995) .
Cognitive and impulsivity measures and their relationship to local grey matter volumes
To characterize the patients and test our hypothesis regarding impulsivity, we had to aggregate the information derived from the comprehensive test battery comprising many different dependent variables. Based on theoretical assumptions and validated by factor analysis, we therefore subsumed selected variables under five domains of executive functions (as described below) and computed positively connoted (i.e. the higher the value, the better the performance) mean zscores for each, which according to our prior hypothesis were partly used as covariates in the voxel-based morphometry analyses: 
Image acquisition
Brain images were acquired on a 1.5T MRI system (Siemens Sonata, Erlangen, Germany) using a 3D T 1 -weighted sequence (magnetization prepared rapid gradient echo) with the following parameters: repetition time = 1900 ms; echo time = 3.93 ms; flip angle = 15 ; 160 contiguous 1 mm sagittal slices; field of view = 240 mm Â 240 mm, matrix size = 240 Â 240, voxel size = 1.0 Â 0.9 Â 1.0 mm.
Voxel-based grey matter volume analysis (local approach)
Data were processed using the SPM5 software (Welcome Department of Imaging Neuroscience Group, London, UK; http://www.fil.ion.ucl. ac.uk/spm). We applied voxel-based morphometry standard routines and default parameters implemented in the voxel-based morphometry 5 toolbox (http://dbm.neuro.uni-jena.de/vbm.html). Images were bias field corrected, tissue classified and registered using linear (12-parameter affine) and non-linear transformations (warping) within the same generative model (Ashburner and Friston, 2005) . Analyses were performed on grey matter segments, which were multiplied by the non-linear components derived from the normalization matrix in order to preserve actual grey matter values locally (modulated grey matter volumes). Grey matter segments were not multiplied by the linear components of the registration in order to account for individual differences in brain orientation, alignment and size globally. Finally, the modulated grey matter volumes were smoothed with a Gaussian kernel of 14 mm full width at half maximum. These smoothed, modulated grey matter volumes are referred to as grey matter.
Total brain and grey matter volume analysis (global approach)
Using the tissue-classified partitions from the voxel-based morphometry analysis [i.e. grey matter, white matter and cerebrospinal fluid (CSF)], overall volumes were determined in cm 3 as the sum of voxels representing grey matter + white matter + CSF (total brain volume), total grey matter volume, total white matter volume and total CSF volume. 
Statistical analysis
Group differences for all demographic, clinical, executive, impulsivity and total volume measures were analysed by means of t-tests and ANOVAs, followed by post hoc analyses with Bonferroni corrections. Voxel-wise grey matter differences between single groups (healthy controls versus all clinical groups and all clinical groups with each other) were examined by using independent-sample t-tests. In order to avoid possible edge effects between different tissue types, we excluded all voxels with grey matter values of 50.1 (absolute threshold masking). Statistical outcomes for the effects of the full-factorial model, the independent-sample t-tests and the correlation analyses were corrected, unless stated otherwise, using false discovery rate (FDR) corrections for multiple comparisons. All significant outcomes were restricted to clusters exceeding different numbers of voxels (spatial extent threshold) in order to decrease the risk of detecting spurious effects due to noise. The spatial extent threshold corresponds to the expected number of voxels per cluster, calculated according to the theory of Gaussian random fields. Although all four groups were carefully matched by age, we conducted all voxel-based morphometry analyses while co-varying for age to rule out according effects.
In order to test our hypothesis that impulsivity would be related to substance abuse as well as grey matter volume decreases in prefrontal areas, we used the mean z-scores of all behavioural impulsivity-related executive measures (i.e. planning and inhibition) and all BIS scores as separate covariates in full-factorial models. We computed a correlation analysis for each, i.e. we performed post hoc Pearson correlations between these variables and the non-adjusted grey matter estimates of co-varying regions. Due to the numerous statistical comparisons or correlation analyses, we considered only those with a type one error of P50.01 in order to minimize the probability to detect false positives. In absence of specific refutable a priori hypothesis for all other executive domains, these were used only to characterize the groups.
Results

Demographic and clinical data
One way ANOVAs of the demographic and clinical variables (Table 1) across the four groups did not yield significant differences for age, education or any relevant clinical measure, except illness onset. Further, as indicated by post hoc analysis, the severity of alcohol consumption (Michigan Alcohol Screening Test) and illegal drug use (Drug Abuse Screening Test) of both addicted groups exceeded that of non-addicted subjects but was comparable between addicted subjects.
Executive functioning and impulsivity data
While the pre-morbid IQ did not differ between groups, significant group differences were found for all executive measures (Table 1) . A significant schizophrenia effect was found for reactive and spontaneous cognitive flexibility. As indicated by the post hoc analysis, both schizophrenic groups showed weaker performances on both measures compared with healthy controls.
We found a significant group effect between addicted (non-schizophrenic) patients and healthy controls for the inhibition domain. The post hoc analysis revealed that addicted patients differed significantly from healthy individuals and showed the largest deficit in this domain. However, the most distinct deficit in comorbid patients was observed for the planning domain. Comorbid patients, compared with non-schizophrenic subjects, showed significantly weaker performances.
Regarding BIS-11 impulsivity measures, we found significant between-group differences in all scales, except for motor impulsivity (Table 1) . As shown in the post hoc analysis, the BIS total score showed that both addicted groups achieved comparable values but significantly higher ones than the healthy subjects. Corresponding to the cognitive domain planning, the BIS non-planning scale showed the most distinct deficit in comorbid patients. Comorbid patients achieved significantly higher nonplanning impulsivity than healthy controls and non-addicted schizophrenics, but did not differ from addicted patients.
Global volume measures
Groups did not differ with respect to total brain volume, white matter or CSF but in total grey matter volume (Table 1) . However, both addicted groups, compared with the healthy control group, showed a significant, and $8% (SZ+A = 7.5%, addicted patients = 8.4%) decreased brain-size adjusted grey matter volume (i.e. adjusted by each individuals' total brain volume). Nonaddicted schizophrenics showed a 3.1% decrease.
Local grey matter volumes
In order to identify relevant group differences, we performed separate two sample t-tests between healthy subjects and all clinical groups (Fig. 1, Table 2 ) as well as between all clinical groups (Table 3 ). All three clinical groups revealed grey matter volume decreases in several frontotemporal clusters as compared with healthy controls. Moreover, addicted patients, compared with healthy controls (healthy controls 4 addicted patients), showed large additional grey matter volume decreases in the anterior cingulate cortex and the frontopolar region. The comorbid patients showed similar but less severe deficits than the addicted patients, whereas non-addicted schizophrenics did not show any decreases (Table 2) .
Both schizophrenia groups differed significantly in four areas (Table 3 ; Fig. 2 ). Corresponding to the healthy controls 4 SZ+A contrast, the SZ 4 SZ+A contrast revealed significant grey matter volume differences in the anterior cingulate cortex, the left frontopolar region and the left superior parietal lobule. However, the reversed contrast (SZ+A4SZ) revealed significant differences only in the right temporopolar cortex [Brodmann area (BA) 38]. Due to the age matching procedure in both schizophrenic groups and their differences in illness onsets, we found between-group differences in illness durations. In order to take these into account we calculated an additional model with illness duration as a covariate. The results showed that the anterior cingulate volume difference lost its significance, at least when FDR corrected for multiple comparisons. However, the influence of illness duration was small as the trend remained (FDR P50.068).
Correlation analyses between local grey matter volumes and impulsivity-related measures (executive domains: inhibition, planning and BIS scores)
Regarding the executive domain inhibition, correlation analyses revealed a common positive relationship between inhibition performance and left frontopolar (BA 10), left anterior cingulate cortex (BA 32), medial orbitofrontal cortex (BA 11) and superior temporal cortex (BA 38) volumes for all groups. This result corresponds with our finding that addicted patients showed the most distinct volume decreases in these areas and also revealed the largest performance deficit in this domain.
The planning performance, which was largely impaired in comorbid patients, was positively correlated with left medial orbitofrontal cortex (BA 11) and right anterior cingulate cortex (BA 24, 32) volumes in all groups. This result partly corresponds with the finding that comorbid patients also showed volume decreases in orbitofrontal cortex and anterior cingulate cortex volumes, compared with non-addicted schizophrenics and/or healthy controls.
Regarding the correlative relationships between BIS impulsivity measures and local grey matter volumes, the most distinct associations could be observed for the left dorsolateral prefrontal cortex volumes (BA 9, Montreal Neurological Institute coordinates: À56, 22, 33), which were negatively correlated with the BIS total score (k = 53, FDR P50.03; r = À0.439, P50.01) and all BIS subscales (motor impulsivity: k = 161, FDR P50.02; r = À0.454, P50.01; non-planning impulsivity: k = 479, FDR P50.05; r = À0.466, P50.01) except attentional impulsivity. However, the attentional impulsivity was negatively correlated with the left supplementary motor cortex volume (BA 6, Montreal Neurological Institute coordinates: À23; À17; 61, k = 123, FDR P50.05; r = À0.478, P50.01). Besides the dorsolateral prefrontal cortex volume correlations, the motor impulsivity was additionally negatively correlated with right medial orbitofrontal cortex volumes (BA 11, Montreal Neurological Institute coordinates: 17; 42; À28, k = 74, FDR P50.02; r = À0.438, P50.01) and the non-planning impulsivity showed an additional negative correlation with left frontopolar volumes (BA 10). This corresponds to the finding that compared with healthy controls and non-addicted schizophrenics, addicted groups showed both the highest non-planning impulsivity and grey matter volume decreases.
Scatter plots illustrating the correlation patterns between local grey matter volumes and inhibition and planning performance as well as non-planning impulsivity are provided in Supplementary  Fig. 1 . 
Discussion
While previous studies assessing brain volumes in schizophreniaaddiction comorbidity focused on structural effects, here we also examined the structure-function relationship between local grey matter volumes and impulsivity. Grey matter volume deficits were found in all clinical groups compared with healthy controls, but were largest in both addicted groups ($8%). However, while temporal and lateral orbitofrontal cortex deficits rather correspond to the schizophrenia diagnosis, the medial orbitofrontal cortex, anterior cingulate cortex, dorsolateral prefrontal cortex and frontopolar volume decreases show more corresponding elements with addiction. Furthermore, as hypothesized, we observed enhanced addiction-related impulsivity which was correlated mainly with the same local grey matter volumes as addiction-related decreased. In accordance with this, comorbid patients compared with non-addicted schizophrenics showed significant volume decreases in the left anterior cingulate cortex and frontopolar cortex. Additionally, and in line with previous studies (Matsuo et al., 2009) , the medial orbitofrontal cortex, which showed volume decreases in both addicted groups compared with healthy controls, was also correlated with most of the impulsivity-related measures.
As indicated by both the self-report measure (BIS score: non-planning impulsivity) and the behaviourally assessed executive domain planning, comorbid patients showed the largest abnormality regarding non-planning impulsivity. These were, except the dorsolateral prefrontal cortex, related to the same grey matter volumes as the inhibition performance, where the addicted patients group showed their largest impairments: orbitofrontal cortex, anterior cingulate cortex and frontopolar volumes (Matsuo et al., 2009; Minzenberg et al., 2009) . However, the result that both addicted groups showed significant structural decreases implies a structure-function relationship between these areas and two dimensions of impulsivity (disinhibition and non-planning) which seem to be strongly related to addiction, as has been reported previously for drug abuse (Jentsch and Taylor, 1999) .
All of these areas are part of different behaviourally relevant frontosubcortical circuits, the superior medial frontosubcortical circuit (anterior cingulate and frontopolar cortex) and the medial orbitofrontal cortex frontosubcortical circuit (Chow and Cummings, 2007) . Each of these interconnected networks comprises projections to the ventral striatum (including ventromedial caudate, ventral putamen, nucleus accumbens), globus pallidus and substantia nigra as well as ventroanterior and dorsomedial nuclei of the thalamus, and closes with projections back to the anterior cingulate cortex and the medial orbitofrontal cortex. While the medial orbitofrontal cortex frontosubcortical circuit was associated with dysregulation of affect, social behaviour and impulsivity in previous studies (Chow and Cummings, 2007) , the superior medial frontosubcortical circuit, especially the anterior cingulate cortex, is known to be of central importance for cognitive control (Kerns et al., 2004; Ridderinkhof et al., 2004) and apathy or amotivational syndrome (Chow and Cummings, 2007) . As suggested previously (Spanagel and Heilig, 2005 ) the disruption of parts of the frontosubcortical circuits in (comorbid) addiction might contribute to the more negative outcome in terms of enhanced impulsivity and antisocial/violent behaviours in addicted and dual-diagnosis patients (Fazel et al., 2009) .
Although not significant, comorbid patients had increased grey matter total volumes compared with addicted non-schizophrenic patients. This might be due to the fact that compared with patients with dual diagnosis, addicted non-schizophrenic patients showed a more severe substance use problem, especially with illegal drugs, and were abstinent only for half as long as comorbid Figure 2 Grey matter volume differences between schizophrenic patients with and without comorbid substance use disorder covaried for age (corrected for multiple comparisons, FDR P50.05; extent threshold = 113 = expected voxels per cluster), as resulted from the independent sample t-test. The colour intensity represents t-statistic values at the voxel level. The results are visualized on standard normalized T 1 -weighted images in selected slices and displayed in neurological convention (right is right).
patients. This, in combination with the fact that both addicted groups in the present study had not used substances for at least one year, may also explain the differences between our results and those reported previously (Mathalon et al., 2003) , where this was not a prerequisite (abstinence duration: alcoholics median = 33 days, comorbid patients = none abstinent). In the present study, the addicted patients group showed the largest volume decreases, thus contrasting with the results of Mathalon et al. (2003) , which showed that the comorbid group suffered from the largest volume decreases.
It is known that alcohol-induced volume decreases partially recover after a 6-9 month period after cessation of drinking (Cardenas et al., 2007) , thus showing early effects of abstinence (after a few weeks) (Bartsch et al., 2007) . However, it is questionable whether complete brain regeneration is possible after having been abstinent for a longer period, or whether the brain recovers from long-term illegal drug use. To clarify this issue, we conducted additional correlation analyses between local grey matter volumes and substance abuse related measures that, except for dependency duration, failed to show significant relationships. Even though the sample size was small, our results indicate a progressive process of grey matter volume losses in frontopolar, middle temporal and cerebellar regions over dependency duration. Additionally, in absence of a positive correlation between abstinence duration and grey matter volumes, they also indicate a steady recovery state in both addicted groups after cessation of drinking or consuming illegal drugs within at least one year.
In agreement with previous findings (Honea et al. 2005) , the most consistent grey matter volume reduction in patients with chronic schizophrenia was found in the right superior temporal cortex (including the temporal pole). However, non-addicted schizophrenics, compared with healthy subjects (healthy controls 4 SZ) and with comorbid patients (SZ+A 4 SZ), showed a significant volume decrease in the temporal pole known to be crucial for theory of mind or social cognition (Frith and Frith, 2003) . While structural and theory of mind-related functional abnormalities in the temporal poles have been previously observed in schizophrenia (Benedetti et al., 2009) , the absence of such theory of mind-related structural impairments in comorbid patients might indicate that comorbid addiction would be associated with preserved mentalizing abilities in schizophrenia, especially as there is evidence showing that dual-diagnosis patients have better social skills than non-addicted schizophrenic patients (Carey et al. 2003 ).
Yet, some methodological concerns of this study should be considered. Firstly, with respect to correlation analyses in voxel-based morphometry studies, performance in specific cognitive domains may only be modulated in part by structural alterations. Secondly, the sample sizes of the subgroups in our experiment were rather small and the variation of substance categories may contribute variation in some measures (e.g. neuropsychological performance). While this design enables the conjoined analysis of two major clinical dimensions, the variations of substance categories may preclude replication of some effects of comorbidity noted from the existing literature and to that extent have to be replicated in larger samples without such a variation. A further specific characteristic of our sample was that both addicted groups had been abstinent for at least 1 year. Assuming that major recovery processes occur within the first year of abstinence, our results suggest a larger stability over time compared with results of patient groups that had been abstinent for shorter periods. Therefore, the reported grey matter volume decreases in these groups are limited to those that persist in spite of abstinence for longer than at least 1 year.
Conclusions
As hypothesized, the results of the present study indicate an increased non-planning impulsivity in addicted, especially dual-diagnosis patients, which is related to grey matter volume losses in medial orbitofrontal cortex, dorsolateral prefrontal cortex, anterior cingulate cortex and frontopolar regions. However, in contrast to non-addicted schizophrenics, comorbid patients showed exacerbated volume decreases only in the anterior cingulate cortex and frontopolar region but not in the medial orbitofrontal cortex or the dorsolateral prefrontal cortex. The previously reported finding, that substance abuse comorbidity represents the main risk factor of schizophrenic patients to become violent (Fazel et al., 2009) , corresponds to the hypothesis that violence is associated with impulsivity that was increased in both addicted groups. Finding this structural relationship between substance abuse, non-planning impulsivity and anterior cingulate and frontopolar volumes in dual-diagnosis patients is of clinical importance and requires further investigation with functional MRI approaches.
